CoChat

Iron: Mammalian defense systems, mechanisms of disease, and chelation therapy approaches

Kontoghiorghes, G.J., Weinberg, E.D. · 1995 · Blood Reviews

The DOI matches its Crossref record; 132 of the 133 references it cites were found in a registry or an index.

Abstract

During the past 6 decades, much attention has been devoted to understanding the uses, metabolism and hazards of iron in living systems. A great variety of heme and non-heme iron-containing enzymes have been characterized in nearly all forms of life. The existence of both ferrous and ferric ions in low- and high-spin configuration, as well as the ability of the metal to function over a wide range of redox potentials, contributes to its unique versatility. Not surprisingly, the singular attributes of iron that permit it to be so useful to life likewise render the metal dangerous to manipulate and to sequester. All vertebrate animals are prone to tissue damage from exposure to excess iron. In order to protect them from this threat, a complex system has evolved to contain and detoxify this metal. This is known as the iron withholding defense system, which mainly serves to scavenge toxic quantities of iron and also for depriving microbial and neoplastic invaders of iron essential for their growth. Since 1970, medical scientists have become increasingly aware of the problems involved in cellular iron homeostasis and of the disease states related to its malfunctioning. Scores of studies have reported that excessive iron in specific tissue sites is associated with development of infection, neoplasia, cardiomyopathy, arthropathy and a variety of endocrine and neurologic deficits. Accordingly, several research groups have attempted to develop chemical agents that might prevent and even eliminate deposits of excess iron. A few of these drugs now are in clinical use, e.g. deferiprone (L1). In the present review, we focus on recent developments in (i) selected aspects of the iron withholding defense system, and (ii) pharmacologic methods that can assist the iron-burdened patient.

Overview

Integrity signals

Registry

Crossref · 10.1016/0268-960x(95)90038-1

Cites

132 of 132 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 132 references

Research works printed but not linked: 16

  1. Smith, 1981, Salivary lactoferrin in cystic fibrosis, Devel Biol Med, 9, 1040
  2. Ganeshaguru, 1992, Cytotoxic mechanisms of iron chelators, Drugs Today, 28, 29
  3. Kontoghiorghes, 1987, New synthetic approach and iron chelation studies of 1-alkyl-2methyl-3-hydroxypyrid-4-ones, Arz Forsch/Drug Res, 37, 1099
  4. Evans, 1992, The effect of alphaketohydroxypyridine chelators on transferrin saturation in vitro and in vivo, Drugs Today, 28, 19
  5. Sheppard, 1992, Synthesis and metabolism of L1 and other novel alpha-ketohydroxypyridine iron chelators and their metal complexes, Drugs Today, 28, 3
  6. 1980, 180, 1
  7. Nebeker, 1984, Aluminium related osteomalagia. Clinical response to desferrioxamine, Kidney Int, 25, 173
  8. Agarwal, 1992, Long-term assessment of efficacy and toxicity of L1 (1,2-dimethyl-3hydroxypyrid-4-one) in transfusion dependent thalassaemia. Indian trial, Drugs Today, 28, 107
  9. Khalifa, 1990, Salicyl-hydroxamic acid (SHAM); a new oral iron chelator for transfusion induced hemosiderosis in beta thalassaemia major, Blood, 76, 65a
  10. Brittenham, 1990, Pyridoxal isonicotinoyl hydrazone, an effective chelator after oral administration, Semin Haematol, 27, 112
  11. Kontoghiorghes, 1990, 1-Ethyl-2-methyl-3-hydroxypyrid-4-one (L1NEt). A new orally effective iron chelator for the treatment of transfusional iron overload, Blood, 76, 66a
  12. 1986, 6, 1
  13. Elorriaga, 1992, Aluminium removal: short- and long-term preliminary results with L1 in rats, Drugs Today, 28, 177
  14. Poltera, 1993, Desferal in human plasmodium Falciparum malaria, Plzen Lek Sborn Suppl, 68, 73
  15. Vreugdenhil, 1992, Iron and iron chelators in rheumatoid arthritis, Drugs Today, 28, 157
  16. Kontoghiorghes, 1992, Oral chelation in the treatment of thalassaemia and other diseases, Drugs Today, 28, 1

Cited by

See all 135

Metadata

Authors
Kontoghiorghes, G. J., & Weinberg, E. D.
Affiliations
  • University of London (GB)
  • Indiana University Bloomington (US)
Corresponding author
Kontoghiorghes, G.J.
Venue
Blood Reviews
Publisher
Elsevier BV
Published
1995-03
Volume
9
Issue
1
Pages
33-45
ISSN
0268-960X (ISSN-L)
OpenAlex
W2102967627
Cited by
134
References
133
Citations by year
2026: 2 · 2024: 1 · 2023: 6 · 2022: 3 · 2021: 2 · 2020: 4 · 2019: 2 · 2018: 3 · 2017: 1 · 2015: 4 · 2013: 3 · 2012: 3
FWCI
1.75
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • Blood Reviews (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
  • Health Sciences › Nursing › Nutrition and Dietetics › Trace Elements in Health
  • Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
Keywords
iron metabolism, iron overload, iron chelation therapy, cellular iron homeostasis, heme iron, non-heme iron, iron toxicity, iron deficiency, iron deficiency anemia
MeSH terms
Animals, Humans, Iron, Chelation Therapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Iron: Mammalian defense systems, mechanisms of disease, and chelation therapy approaches. https://app.cochat.ai/papers/10.1016/0268-960x(95)90038-1
The paper
Kontoghiorghes, G. J., & Weinberg, E. D. (1995). Iron: Mammalian defense systems, mechanisms of disease, and chelation therapy approaches. Blood Reviews. https://doi.org/10.1016/0268-960x(95)90038-1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.